AEGiS-Bangkok Post: Abbott agrees to lower price of Aids drug

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

Abbott agrees to lower price of Aids drug

Bangkok Post - April 11, 2007

US-based drug maker Abbott Laboratories has agreed to lower the price of its Aids drug Kaletra from 5,938 baht per patient per month to 3,488.20 baht. Siriwat Tiptaradol, the Food and Drug Administration's (FDA) secretary-general, said the new price could make Kaletra cheaper than the generic version.

The firm's proposal to cut the drug price is seen as a means to end the dispute with the Public Health Ministry over the high price of Kaletra that led to the ministry's decision to break the drug patent earlier this year.

Speaking after yesterday's meeting with representatives from patent-holding companies, Mr Siriwat said Abbott insisted that it disagreed with the issuance of compulsory licenses, so it opted for a discount on the drug's price instead.

Aids Access Foundation's director Nimit Tienudom hailed the firm's discount proposal.

"This is what the patients and health activists have been waiting for. This is apparently a consequence of the government's decision to break the drug patent," said Mr Nimit.

070411
BP070402

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .